Baidu
map

Medscape:2013年美国内分泌医师薪酬报告

2014-07-09 desperado-c 丁香园

今年,共有25个专科,超过24000名医师参加了Medscape美国医师薪酬调查报告,记述的内容包括他们2013年薪酬、工作时间、医疗改革所对他们的影响,以及他们对新医疗环境的适应情况等。现将Medscape2014年美国内分泌医师薪酬报告主要内容编译如下: 2013年美国内分泌医师薪酬调查结果 Medscape 2014年美国医师薪酬报告中,内分泌医师平均年薪184000

今年,共有25个专科,超过24000名医师参加了Medscape美国医师薪酬调查报告,记述的内容包括他们2013年薪酬、工作时间、医疗改革所对他们的影响,以及他们对新医疗环境的适应情况等。现将Medscape 2013年美国内分泌医师薪酬报告主要内容编译如下:

2013年美国内分泌医师薪酬调查结果




Medscape 2014年美国医师薪酬报告中,内分泌医师平均年薪184000美元,在所有临床医师中排名倒数第四。其他收入排名后五位的还包括HIV/ID医师、初级保健医师和儿科医师。与上一次Medscape美国临床医师薪酬报告相似,骨科医师收入最高,其次为心脏病医师,泌尿外科医师和消化科医师排名并列第三。与以往相似,与那些治疗慢性病的医师相比,手术医师的收入更高。此次调查统计的收入仅涉及全职工作所得,包括薪酬、奖金和分红。而且,这些都是税后和扣除营业开支后的收入,而非税前收入,也不包括与患者诊疗无关的收入。

美国内分泌医师收入的变化


美国内分泌医师的收入较往年有所提高,大约增加了3.2%。有趣的是,一些专科(包含手术科室)医师的薪酬较前有小幅下降,而初级保健医师的薪酬则有小幅提高,反映了平价医疗法案实施后引起的薪酬早期变化。

男性内分泌医师收入高,还是女性内分泌医师收入高


2013年,美国大约有一半刚毕业医师为女性,而且,61%女医师年龄在45岁以下,而男医生中年龄在45岁以下者仅有38%。与Medscape2010年临床医师薪酬报告相比,今年参加调查的男女医生收入都有所提高,但是,男医生的收入仍然更高一点。依据今年的Medscape临床医师薪酬调查,美国男性内分泌医师的年薪为195000美元,远远超过女性内分泌医师的161000美元。这点与上一年年调查结果相一致,而且,从所有受调查医师的薪酬来看,男医师的收入也高于女医师。

美国内分泌医师对他们的收入是否满意

虽然女内分泌医师的收入低于男内分泌医师,但是,出人意料的是,男女内分泌医师对他们的收入满意度相同,均为41%。与所有受调查医师的满意度(满意度为50%)相比,内分泌医师对他们收入的满意度偏低。

美国内分泌医师收入的地区差异

居住在美国西部和东北部地区的内分泌医师收入最高,年薪分别为203000美元和202000美元。与大多数专业不同,大多数专业东北部医师的收入最低。美国西北地区的内分泌医师收入最低,为129000美元,收入倒数第二的是西南地区,为150000美元。

谁的收入更高,受聘内分泌医师还是自由职业内分泌医师


在这项调查中,受聘内分泌医师的平均年薪为173000美元,低于自由职业内分泌医师的203000美元。受聘医师最常见的付款方式是薪金制,同时,越来越多的受聘医师也被要求要完成生产指标。据纽约时报报道,去年医院有64%职位有空缺,而2004年仅有11%。最近的另外一项Medscape报告表明,近49%受聘医师对自己的收入比较满意,这可能是由于,与自由职业相比,即使挣得少一些,但有一份稳定的收入,而且拿同样的薪水可能做较少的工作。

不同执业环境中内分泌医师薪酬的差异


自由职业医师赚的钱比受聘医师多,这种情况打破了不同执业环境收入不同的局面,形成了一种更为微妙的局面。诊所联合执业的内分泌医师收入最高,专科诊所工作的内分泌医师年薪为207000美元,而在多学科诊所工作内分泌医师年薪为200000美元,私人诊所内分泌医师收入排在第三,年薪为174000美元,而门诊诊所的内分泌收入最低,为154000美元。

如果可以重新选择,你会……


在所有受调查内分泌医师中,如果可以重新选择,57%受试者还会选择医学,而且50%受试者还会选择做内分泌医师,但是,关于执业环境,仅有22%受试者会做相同的决定。在所有受调查医师中,58%受试者会选择医学,47%受试者会选择相同的专业,但仅有26%受试者会选择相同的执业环境。

内分泌医师总体职业满意度情况


尽管57%内分泌医师会再次选择医学,但其总体职业满意度仅为49%,在所有受调查医师中排名倒数第8。总体职业满意度最高的是皮肤科医师,为65%,其次为精神科医师,为58%。总体职业满意度最低的为整形外科医师,为45%,其次为神经科医师和内科医师,两者均为47%。

支付方式选择


25%美国内分泌医师已加入责任制医疗组织(ACOs),另有12%内分泌医师计划于今年加入ACOs。按服务项目付费和私人诊所则是美国最主要的支付方式和执业环境,而加入ACOs医师比例显著高于其他支付支付方式。

是否会拒绝医保或医疗救助患者


在今年Medscape医师薪酬报告中,17%自由职业内分泌医师和5%受聘内分泌医师称,他们有可能拒绝新医保或医疗救助患者。73%受聘内分泌医师和52%自由职业内分泌医师称,他们有可能继续接收新医保或医疗救助患者。受聘内分泌医师和自由职业内分泌医师中各有约四分子一仍不确定是否会继续接收新医保或医疗救助患者。

是否会放弃不良保险公司的承保对象



在此次Medscape调查中,31%内分泌医师称他们会放弃不良保险公司的承保对象,37%内分泌医师称他们不会放弃不良保险公司的承保对象。私人保险覆盖了美国约63%就诊患者。依据2009至2010年美国疾病预防与控制中心的数据,89%初级保健医师和94%专科医师接受私人保险公司承保对象。

是否开始提供辅助性服务


在此次Medscape调查中,14%受聘内分泌医师和22%自由职业内分泌医师提供辅助性服务。这些辅助性服务包括实验室检查、诊断服务、体重管理和足部护理。

是否会与患者讨论诊疗费用


参与这项调查的内分泌医师中,83%会定期或不定期与患者讨论诊疗费用。在最近一项Medscape投票中,38%健康专业人士认为医师应准备好与患者讨论这些问题,41%认为医师没有这个义务,他们不认为医师需要为这种谈话做准备。

每周花费在患者身上的时间


参与这项调查的内分泌医师中,44%内分泌医师称每周花费在看病人上的时间≤40小时,54%内分泌医师称每周花费在患者身上的时间超过40小时,仅有2%内分泌医师称从不看病人。2010年,发表在JAMA杂志上的一项研究发现,1997年至2007年期间,美国医师花费在患者身上的时间稳定的下降,从每周54.6小时降至51小时,无论是男医师还是女医师,抑或受聘医师还是自由职业医师,每周花费在患者身上的时间都在减少。

每周看多少例患者



参与这项调查的内分泌医师中,37%内分泌医师称每周看25至75例患者,41%内分泌医师称每周每周看76只124例患者,9%内分泌医师称每周看超过125例患者。

花费在每例患者身上的时间


在此次Medscape医师薪酬报告,32%内分泌医师称花费在每例患者身上的时间≤16分钟,66%内分泌医师称花费在每例患者身上的时间>16分钟。相比之下,仅有48%初级保健医师称花费在每例患者身上的时间>16分钟。

每周花费在书写和行政上的时间


依据此次Medscape医师薪酬报告,35%自由职业内分泌医师和41%受聘内分泌医师称每周至少花费10小时用于写病历和行政工作。这点远超其他专业医师,在其他专业医师中,仅有26%自由职业医师和35%受聘医师称每周至少花费10小时用于写病历。

工作中最有成就感的部分


尽管遭遇过挫折吗,但是,大部分医师还是认为他们的工作非常有意义。41%内分泌医师选择善于行医为最重要的奖励,38%内分泌医师选择与患者相处,11%内分泌医师选择“让世界变得更美好”,3%内分泌医师选择自豪能成为一名医生,另有3%内分泌医师选择能赚到很多钱。小部分医生还提到了其他的收获。

收入是否会随着健康保险交易而所变化


46%内分泌医师认为他们来自健康保险交易的收入有所减少,50%内分泌医师认为他们的收入没有变化,仅有3%内分泌医师认为他们的收入会增加。内分泌医师和其他专业医师一样悲观,43%其他专业医师认为他们的收入会减少。

不同专科调查反馈情况



调查方法


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2075866, encodeId=7fdb20e5866e3, content=<a href='/topic/show?id=a9b78845200' target=_blank style='color:#2F92EE;'>#薪酬报告#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88452, encryptionId=a9b78845200, topicName=薪酬报告)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3679417, createdName=feather78, createdTime=Sat Jan 10 13:24:00 CST 2015, time=2015-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1682180, encodeId=b5041682180d7, content=<a href='/topic/show?id=d4d031e8074' target=_blank style='color:#2F92EE;'>#分泌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31780, encryptionId=d4d031e8074, topicName=分泌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0da227938338, createdName=gwc392, createdTime=Thu Feb 12 15:24:00 CST 2015, time=2015-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1725633, encodeId=bd261e256333f, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Wed Jan 14 23:24:00 CST 2015, time=2015-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1897959, encodeId=2d73189e95973, content=<a href='/topic/show?id=832c404308' target=_blank style='color:#2F92EE;'>#CAP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4043, encryptionId=832c404308, topicName=CAP)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c39f145, createdName=smlt2008, createdTime=Sun Mar 29 08:24:00 CST 2015, time=2015-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1350958, encodeId=af8e13509584c, content=<a href='/topic/show?id=f5a31596056' target=_blank style='color:#2F92EE;'>#SCAP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15960, encryptionId=f5a31596056, topicName=SCAP)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Fri Jul 11 00:24:00 CST 2014, time=2014-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1458559, encodeId=ed6714585597b, content=<a href='/topic/show?id=6b5511492e2' target=_blank style='color:#2F92EE;'>#Medscape#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11492, encryptionId=6b5511492e2, topicName=Medscape)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4ab6090887, createdName=bnjfx@128.com, createdTime=Fri Jul 11 00:24:00 CST 2014, time=2014-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1553062, encodeId=f27115530625a, content=<a href='/topic/show?id=f983884456a' target=_blank style='color:#2F92EE;'>#薪酬#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88445, encryptionId=f983884456a, topicName=薪酬)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccd914357372, createdName=维他命, createdTime=Fri Jul 11 00:24:00 CST 2014, time=2014-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606235, encodeId=6cf3160623594, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Fri Jul 11 00:24:00 CST 2014, time=2014-07-11, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2075866, encodeId=7fdb20e5866e3, content=<a href='/topic/show?id=a9b78845200' target=_blank style='color:#2F92EE;'>#薪酬报告#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88452, encryptionId=a9b78845200, topicName=薪酬报告)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3679417, createdName=feather78, createdTime=Sat Jan 10 13:24:00 CST 2015, time=2015-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1682180, encodeId=b5041682180d7, content=<a href='/topic/show?id=d4d031e8074' target=_blank style='color:#2F92EE;'>#分泌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31780, encryptionId=d4d031e8074, topicName=分泌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0da227938338, createdName=gwc392, createdTime=Thu Feb 12 15:24:00 CST 2015, time=2015-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1725633, encodeId=bd261e256333f, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Wed Jan 14 23:24:00 CST 2015, time=2015-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1897959, encodeId=2d73189e95973, content=<a href='/topic/show?id=832c404308' target=_blank style='color:#2F92EE;'>#CAP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4043, encryptionId=832c404308, topicName=CAP)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c39f145, createdName=smlt2008, createdTime=Sun Mar 29 08:24:00 CST 2015, time=2015-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1350958, encodeId=af8e13509584c, content=<a href='/topic/show?id=f5a31596056' target=_blank style='color:#2F92EE;'>#SCAP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15960, encryptionId=f5a31596056, topicName=SCAP)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Fri Jul 11 00:24:00 CST 2014, time=2014-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1458559, encodeId=ed6714585597b, content=<a href='/topic/show?id=6b5511492e2' target=_blank style='color:#2F92EE;'>#Medscape#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11492, encryptionId=6b5511492e2, topicName=Medscape)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4ab6090887, createdName=bnjfx@128.com, createdTime=Fri Jul 11 00:24:00 CST 2014, time=2014-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1553062, encodeId=f27115530625a, content=<a href='/topic/show?id=f983884456a' target=_blank style='color:#2F92EE;'>#薪酬#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88445, encryptionId=f983884456a, topicName=薪酬)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccd914357372, createdName=维他命, createdTime=Fri Jul 11 00:24:00 CST 2014, time=2014-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606235, encodeId=6cf3160623594, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Fri Jul 11 00:24:00 CST 2014, time=2014-07-11, status=1, ipAttribution=)]
    2015-02-12 gwc392
  3. [GetPortalCommentsPageByObjectIdResponse(id=2075866, encodeId=7fdb20e5866e3, content=<a href='/topic/show?id=a9b78845200' target=_blank style='color:#2F92EE;'>#薪酬报告#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88452, encryptionId=a9b78845200, topicName=薪酬报告)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3679417, createdName=feather78, createdTime=Sat Jan 10 13:24:00 CST 2015, time=2015-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1682180, encodeId=b5041682180d7, content=<a href='/topic/show?id=d4d031e8074' target=_blank style='color:#2F92EE;'>#分泌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31780, encryptionId=d4d031e8074, topicName=分泌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0da227938338, createdName=gwc392, createdTime=Thu Feb 12 15:24:00 CST 2015, time=2015-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1725633, encodeId=bd261e256333f, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Wed Jan 14 23:24:00 CST 2015, time=2015-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1897959, encodeId=2d73189e95973, content=<a href='/topic/show?id=832c404308' target=_blank style='color:#2F92EE;'>#CAP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4043, encryptionId=832c404308, topicName=CAP)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c39f145, createdName=smlt2008, createdTime=Sun Mar 29 08:24:00 CST 2015, time=2015-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1350958, encodeId=af8e13509584c, content=<a href='/topic/show?id=f5a31596056' target=_blank style='color:#2F92EE;'>#SCAP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15960, encryptionId=f5a31596056, topicName=SCAP)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Fri Jul 11 00:24:00 CST 2014, time=2014-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1458559, encodeId=ed6714585597b, content=<a href='/topic/show?id=6b5511492e2' target=_blank style='color:#2F92EE;'>#Medscape#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11492, encryptionId=6b5511492e2, topicName=Medscape)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4ab6090887, createdName=bnjfx@128.com, createdTime=Fri Jul 11 00:24:00 CST 2014, time=2014-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1553062, encodeId=f27115530625a, content=<a href='/topic/show?id=f983884456a' target=_blank style='color:#2F92EE;'>#薪酬#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88445, encryptionId=f983884456a, topicName=薪酬)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccd914357372, createdName=维他命, createdTime=Fri Jul 11 00:24:00 CST 2014, time=2014-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606235, encodeId=6cf3160623594, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Fri Jul 11 00:24:00 CST 2014, time=2014-07-11, status=1, ipAttribution=)]
    2015-01-14 feather89
  4. [GetPortalCommentsPageByObjectIdResponse(id=2075866, encodeId=7fdb20e5866e3, content=<a href='/topic/show?id=a9b78845200' target=_blank style='color:#2F92EE;'>#薪酬报告#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88452, encryptionId=a9b78845200, topicName=薪酬报告)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3679417, createdName=feather78, createdTime=Sat Jan 10 13:24:00 CST 2015, time=2015-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1682180, encodeId=b5041682180d7, content=<a href='/topic/show?id=d4d031e8074' target=_blank style='color:#2F92EE;'>#分泌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31780, encryptionId=d4d031e8074, topicName=分泌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0da227938338, createdName=gwc392, createdTime=Thu Feb 12 15:24:00 CST 2015, time=2015-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1725633, encodeId=bd261e256333f, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Wed Jan 14 23:24:00 CST 2015, time=2015-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1897959, encodeId=2d73189e95973, content=<a href='/topic/show?id=832c404308' target=_blank style='color:#2F92EE;'>#CAP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4043, encryptionId=832c404308, topicName=CAP)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c39f145, createdName=smlt2008, createdTime=Sun Mar 29 08:24:00 CST 2015, time=2015-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1350958, encodeId=af8e13509584c, content=<a href='/topic/show?id=f5a31596056' target=_blank style='color:#2F92EE;'>#SCAP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15960, encryptionId=f5a31596056, topicName=SCAP)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Fri Jul 11 00:24:00 CST 2014, time=2014-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1458559, encodeId=ed6714585597b, content=<a href='/topic/show?id=6b5511492e2' target=_blank style='color:#2F92EE;'>#Medscape#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11492, encryptionId=6b5511492e2, topicName=Medscape)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4ab6090887, createdName=bnjfx@128.com, createdTime=Fri Jul 11 00:24:00 CST 2014, time=2014-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1553062, encodeId=f27115530625a, content=<a href='/topic/show?id=f983884456a' target=_blank style='color:#2F92EE;'>#薪酬#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88445, encryptionId=f983884456a, topicName=薪酬)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccd914357372, createdName=维他命, createdTime=Fri Jul 11 00:24:00 CST 2014, time=2014-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606235, encodeId=6cf3160623594, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Fri Jul 11 00:24:00 CST 2014, time=2014-07-11, status=1, ipAttribution=)]
    2015-03-29 smlt2008
  5. [GetPortalCommentsPageByObjectIdResponse(id=2075866, encodeId=7fdb20e5866e3, content=<a href='/topic/show?id=a9b78845200' target=_blank style='color:#2F92EE;'>#薪酬报告#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88452, encryptionId=a9b78845200, topicName=薪酬报告)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3679417, createdName=feather78, createdTime=Sat Jan 10 13:24:00 CST 2015, time=2015-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1682180, encodeId=b5041682180d7, content=<a href='/topic/show?id=d4d031e8074' target=_blank style='color:#2F92EE;'>#分泌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31780, encryptionId=d4d031e8074, topicName=分泌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0da227938338, createdName=gwc392, createdTime=Thu Feb 12 15:24:00 CST 2015, time=2015-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1725633, encodeId=bd261e256333f, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Wed Jan 14 23:24:00 CST 2015, time=2015-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1897959, encodeId=2d73189e95973, content=<a href='/topic/show?id=832c404308' target=_blank style='color:#2F92EE;'>#CAP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4043, encryptionId=832c404308, topicName=CAP)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c39f145, createdName=smlt2008, createdTime=Sun Mar 29 08:24:00 CST 2015, time=2015-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1350958, encodeId=af8e13509584c, content=<a href='/topic/show?id=f5a31596056' target=_blank style='color:#2F92EE;'>#SCAP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15960, encryptionId=f5a31596056, topicName=SCAP)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Fri Jul 11 00:24:00 CST 2014, time=2014-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1458559, encodeId=ed6714585597b, content=<a href='/topic/show?id=6b5511492e2' target=_blank style='color:#2F92EE;'>#Medscape#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11492, encryptionId=6b5511492e2, topicName=Medscape)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4ab6090887, createdName=bnjfx@128.com, createdTime=Fri Jul 11 00:24:00 CST 2014, time=2014-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1553062, encodeId=f27115530625a, content=<a href='/topic/show?id=f983884456a' target=_blank style='color:#2F92EE;'>#薪酬#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88445, encryptionId=f983884456a, topicName=薪酬)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccd914357372, createdName=维他命, createdTime=Fri Jul 11 00:24:00 CST 2014, time=2014-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606235, encodeId=6cf3160623594, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Fri Jul 11 00:24:00 CST 2014, time=2014-07-11, status=1, ipAttribution=)]
    2014-07-11 zhaojie88
  6. [GetPortalCommentsPageByObjectIdResponse(id=2075866, encodeId=7fdb20e5866e3, content=<a href='/topic/show?id=a9b78845200' target=_blank style='color:#2F92EE;'>#薪酬报告#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88452, encryptionId=a9b78845200, topicName=薪酬报告)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3679417, createdName=feather78, createdTime=Sat Jan 10 13:24:00 CST 2015, time=2015-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1682180, encodeId=b5041682180d7, content=<a href='/topic/show?id=d4d031e8074' target=_blank style='color:#2F92EE;'>#分泌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31780, encryptionId=d4d031e8074, topicName=分泌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0da227938338, createdName=gwc392, createdTime=Thu Feb 12 15:24:00 CST 2015, time=2015-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1725633, encodeId=bd261e256333f, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Wed Jan 14 23:24:00 CST 2015, time=2015-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1897959, encodeId=2d73189e95973, content=<a href='/topic/show?id=832c404308' target=_blank style='color:#2F92EE;'>#CAP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4043, encryptionId=832c404308, topicName=CAP)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c39f145, createdName=smlt2008, createdTime=Sun Mar 29 08:24:00 CST 2015, time=2015-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1350958, encodeId=af8e13509584c, content=<a href='/topic/show?id=f5a31596056' target=_blank style='color:#2F92EE;'>#SCAP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15960, encryptionId=f5a31596056, topicName=SCAP)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Fri Jul 11 00:24:00 CST 2014, time=2014-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1458559, encodeId=ed6714585597b, content=<a href='/topic/show?id=6b5511492e2' target=_blank style='color:#2F92EE;'>#Medscape#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11492, encryptionId=6b5511492e2, topicName=Medscape)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4ab6090887, createdName=bnjfx@128.com, createdTime=Fri Jul 11 00:24:00 CST 2014, time=2014-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1553062, encodeId=f27115530625a, content=<a href='/topic/show?id=f983884456a' target=_blank style='color:#2F92EE;'>#薪酬#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88445, encryptionId=f983884456a, topicName=薪酬)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccd914357372, createdName=维他命, createdTime=Fri Jul 11 00:24:00 CST 2014, time=2014-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606235, encodeId=6cf3160623594, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Fri Jul 11 00:24:00 CST 2014, time=2014-07-11, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=2075866, encodeId=7fdb20e5866e3, content=<a href='/topic/show?id=a9b78845200' target=_blank style='color:#2F92EE;'>#薪酬报告#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88452, encryptionId=a9b78845200, topicName=薪酬报告)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3679417, createdName=feather78, createdTime=Sat Jan 10 13:24:00 CST 2015, time=2015-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1682180, encodeId=b5041682180d7, content=<a href='/topic/show?id=d4d031e8074' target=_blank style='color:#2F92EE;'>#分泌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31780, encryptionId=d4d031e8074, topicName=分泌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0da227938338, createdName=gwc392, createdTime=Thu Feb 12 15:24:00 CST 2015, time=2015-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1725633, encodeId=bd261e256333f, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Wed Jan 14 23:24:00 CST 2015, time=2015-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1897959, encodeId=2d73189e95973, content=<a href='/topic/show?id=832c404308' target=_blank style='color:#2F92EE;'>#CAP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4043, encryptionId=832c404308, topicName=CAP)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c39f145, createdName=smlt2008, createdTime=Sun Mar 29 08:24:00 CST 2015, time=2015-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1350958, encodeId=af8e13509584c, content=<a href='/topic/show?id=f5a31596056' target=_blank style='color:#2F92EE;'>#SCAP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15960, encryptionId=f5a31596056, topicName=SCAP)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Fri Jul 11 00:24:00 CST 2014, time=2014-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1458559, encodeId=ed6714585597b, content=<a href='/topic/show?id=6b5511492e2' target=_blank style='color:#2F92EE;'>#Medscape#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11492, encryptionId=6b5511492e2, topicName=Medscape)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4ab6090887, createdName=bnjfx@128.com, createdTime=Fri Jul 11 00:24:00 CST 2014, time=2014-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1553062, encodeId=f27115530625a, content=<a href='/topic/show?id=f983884456a' target=_blank style='color:#2F92EE;'>#薪酬#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88445, encryptionId=f983884456a, topicName=薪酬)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccd914357372, createdName=维他命, createdTime=Fri Jul 11 00:24:00 CST 2014, time=2014-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606235, encodeId=6cf3160623594, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Fri Jul 11 00:24:00 CST 2014, time=2014-07-11, status=1, ipAttribution=)]
    2014-07-11 维他命
  8. [GetPortalCommentsPageByObjectIdResponse(id=2075866, encodeId=7fdb20e5866e3, content=<a href='/topic/show?id=a9b78845200' target=_blank style='color:#2F92EE;'>#薪酬报告#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88452, encryptionId=a9b78845200, topicName=薪酬报告)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3679417, createdName=feather78, createdTime=Sat Jan 10 13:24:00 CST 2015, time=2015-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1682180, encodeId=b5041682180d7, content=<a href='/topic/show?id=d4d031e8074' target=_blank style='color:#2F92EE;'>#分泌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31780, encryptionId=d4d031e8074, topicName=分泌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0da227938338, createdName=gwc392, createdTime=Thu Feb 12 15:24:00 CST 2015, time=2015-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1725633, encodeId=bd261e256333f, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Wed Jan 14 23:24:00 CST 2015, time=2015-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1897959, encodeId=2d73189e95973, content=<a href='/topic/show?id=832c404308' target=_blank style='color:#2F92EE;'>#CAP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4043, encryptionId=832c404308, topicName=CAP)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c39f145, createdName=smlt2008, createdTime=Sun Mar 29 08:24:00 CST 2015, time=2015-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1350958, encodeId=af8e13509584c, content=<a href='/topic/show?id=f5a31596056' target=_blank style='color:#2F92EE;'>#SCAP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15960, encryptionId=f5a31596056, topicName=SCAP)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Fri Jul 11 00:24:00 CST 2014, time=2014-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1458559, encodeId=ed6714585597b, content=<a href='/topic/show?id=6b5511492e2' target=_blank style='color:#2F92EE;'>#Medscape#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11492, encryptionId=6b5511492e2, topicName=Medscape)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4ab6090887, createdName=bnjfx@128.com, createdTime=Fri Jul 11 00:24:00 CST 2014, time=2014-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1553062, encodeId=f27115530625a, content=<a href='/topic/show?id=f983884456a' target=_blank style='color:#2F92EE;'>#薪酬#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88445, encryptionId=f983884456a, topicName=薪酬)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccd914357372, createdName=维他命, createdTime=Fri Jul 11 00:24:00 CST 2014, time=2014-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606235, encodeId=6cf3160623594, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Fri Jul 11 00:24:00 CST 2014, time=2014-07-11, status=1, ipAttribution=)]
Baidu
map
Baidu
map
Baidu
map